These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9608351)

  • 1. Dosage effects of methylphenidate on the social behavior of adolescents diagnosed with attention-deficit hyperactivity disorder.
    Smith BH; Pelham WE; Evans S; Gnagy E; Molina B; Bukstein O; Greiner A; Myak C; Presnell M; Willoughby M
    Exp Clin Psychopharmacol; 1998 May; 6(2):187-204. PubMed ID: 9608351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG; Kolko DJ
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints.
    Rapport MD; Randall R; Moffitt C
    J Atten Disord; 2002 Jun; 6(1):15-24. PubMed ID: 12045757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-response effects of methylphenidate on ecologically valid measures of academic performance and classroom behavior in adolescents with ADHD.
    Evans SW; Pelham WE; Smith BH; Bukstein O; Gnagy EM; Greiner AR; Altenderfer L; Baron-Myak C
    Exp Clin Psychopharmacol; 2001 May; 9(2):163-75. PubMed ID: 11518092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empathy and Facial Expression Recognition in Children With and Without Attention-Deficit/Hyperactivity Disorder: Effects of Stimulant Medication on Empathic Skills in Children with Attention-Deficit/Hyperactivity Disorder.
    Gumustas F; Yilmaz I; Yulaf Y; Gokce S; Sabuncuoglu O
    J Child Adolesc Psychopharmacol; 2017 Jun; 27(5):433-439. PubMed ID: 28332851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive school-based behavioral assessment of the effects of methylphenidate.
    Gulley V; Northup J
    J Appl Behav Anal; 1997; 30(4):627-38. PubMed ID: 9433788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylphenidate and behavior modification in children with ADHD and comorbid ODD or CD: main and incremental effects across settings.
    Kolko DJ; Bukstein OG; Barron J
    J Am Acad Child Adolesc Psychiatry; 1999 May; 38(5):578-86. PubMed ID: 10230190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily multilayer-release methylphenidate in a double-blind, crossover comparison to immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.
    Weiss M; Hechtman L; Turgay A; Jain U; Quinn D; Ahmed TS; Yates T; Reiz JL; Donnelly GA; Harsanyi Z; Darke AC
    J Child Adolesc Psychopharmacol; 2007 Oct; 17(5):675-88. PubMed ID: 17979587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and therapeutic effect of OROS methylphenidate under different breakfast conditions in children with attention-deficit/hyperactivity disorder.
    Wigal SB; Gupta S; Heverin E; Starr HL
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):255-63. PubMed ID: 21663428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.
    Lipkin PH; Butz AM; Cozen MA
    J Child Adolesc Psychopharmacol; 2003; 13(1):103-6. PubMed ID: 12804131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transitioning from extended-release methylphenidate onto osmotic, controlled-release methylphenidate in children/adolescents with ADHD: results of a 3-month non-interventional study.
    Wolff C; Alfred A; Lindermüller A; Rettig K; Mattejat F; Gerwe M; Slawik L; Schäuble B
    Curr Med Res Opin; 2011; 27 Suppl 2():35-44. PubMed ID: 21787126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Executive impairment determines ADHD medication response: implications for academic achievement.
    Hale JB; Reddy LA; Semrud-Clikeman M; Hain LA; Whitaker J; Morley J; Lawrence K; Smith A; Jones N
    J Learn Disabil; 2011; 44(2):196-212. PubMed ID: 21383110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
    Wigal SB; Nordbrock E; Adjei AL; Childress A; Kupper RJ; Greenhill L
    CNS Drugs; 2015 Apr; 29(4):331-40. PubMed ID: 25877989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary evidence of beneficial effects of methylphenidate on listening comprehension in children with attention-deficit/hyperactivity disorder.
    McInnes A; Bedard AC; Hogg-Johnson S; Tannock R
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):35-49. PubMed ID: 17343552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
    Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
    Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of two long-acting methylphenidate formulations in children with attention- deficit/hyperactivity disorder in a laboratory classroom setting.
    Silva R; Muniz R; Pestreich LK; Brams M; Childress A; Lopez FA
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):637-54. PubMed ID: 16190795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
    Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
    Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.